An evidence session that forms part of a UK parliament select committee's inquiry into clinical trials has been rescheduled.
The House of Commons Science and Technology Committee’s evidence session due to take place on 17 April has been moved to the 22 April.
The committee will summon representatives from charities and industry including James Shannon, the chief medical officer at GlaxoSmithKline, and Sharmila Nebhrajani, the chief executive of the Association of Medical Research Charities.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.